首页> 外国专利> Marker-adapted normal tissue injury probability

Marker-adapted normal tissue injury probability

机译:适应标记的正常组织损伤概率

摘要

A therapy system includes a diagnostic image scanner (12) that acquires a diagnostic image of a target region to be treated. A planning processor (70) is configured to generate a patient specific adaptive radiation therapy plan based on patient specific biomarkers before and during therapy. A first set of patient specific biomarkers is determined then used for the determination of a first normal tissue complication probability (NTCP) model and a first tumor control probability (TCP) model. A radiation therapy device (40) administers a first dose of radiation to the target region with a protocol based on the first NTCP model and the first TCP model. A second set of patient specific biomarkers is determined. A relationship between the first set and second set of patient specific biomarkers is used to determine a second NTCP model and a second TCP model. The radiation therapy device (40) administers a second dose of radiation to the target region with a protocol based on the second NTCP model and second TCP model.
机译:一种治疗系统,包括诊断图像扫描仪(12),其获取要治疗的目标区域的诊断图像。规划处理器(70)被配置为基于患者特定的生物标记在治疗之前和期间生成患者特定的适应性放射治疗计划。确定第一组患者特异性生物标记,然后将其用于确定第一正常组织并发症概率(NTCP)模型和第一肿瘤控制概率(TCP)模型。放射线治疗装置(40)利用基于第一NTCP模型和第一TCP模型的协议对目标区域照射第一剂量的放射线。确定第二组患者特异性生物标志物。患者特异性生物标志物的第一组和第二组之间的关系用于确定第二NTCP模型和第二TCP模型。放射线治疗装置(40)利用基于第二NTCP模型和第二TCP模型的协议,对目标区域照射第二剂量的放射线。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号